+7 (701) 759 90 19
USD 424.99 EUR 504.21
RUB 5.81 CNY 65.66
News

Kazakhstan to publish detailed clinical trial data for QazVac COVID-19 vaccine

16 June 2021 14:45
Share in:
Kazakhstan to publish detailed clinical trial data for QazVac COVID-19 vaccine

NUR-SULTAN. KAZINFORM – Kazakhstan is to publish detailed data for the clinical trials of the QazVac vaccine against COVID-19 soon, Kazakh Health Minister Alexei Tsoi said, Kazinform correspondent reports.

Related news
Almaty rgn posts over 310 new daily COVID-19 cases Kazakhstan reports 86 COVID-19 fatalities in past day Over 100 thou COVID-19 patients receive treatment in Kazakhstan

According to the Kazakh health minister, Kazakhstan’s achievement in developing its own QazVac COVID-19 vaccine was acknowledged by the medical community. The vaccine was authorized for use and is in the clinical use in the country after passing clinical trials.

He went on to say that more detailed data for the clinical trials of the Kazakh QazVac COVID-19 vaccine will be published soon.

Earlier the minister said that around 800 people have re-infected with the coronavirus infection in Kazakhstan.



Share in:

Author:

Adlet Seilkhanov

Related news
Read also
+7
Send
Employees online
Editor
Seilkhanov Adlet
Seilkhanov Adlet
954-048

Archive